Malignant bowel obstruction. Review
Keywords:
Intestinal obstruction, Neoplasms, Surgical procedures, Palliative careAbstract
Malignant intestinal obstruction is a complex disease that, despite the low prevalence, causes a high level of discomfort, due to the secondary symptoms produced by various mechanical and functional alterations in the different pathophysiological mechanisms. These symptoms include occlusion of the intestinal lumen, changes in motility, and accumulation of secretions. The treatment of the malignant intestinal obstruction must be individualized to each patient in order to establish the best strategy, either surgical intervention — decompressive gastrostomy or jejunostomy, performing of ostomies and vascular stents — or a medical treatment — opioids, anticholinergics, antiemetics, and steroids. A strategy that synergically combines the different options is generally recommended, in order to achieve suitable control of the symptoms.
Author Biographies
John Cárdenas, Universidad Militar Nueva Granada
Medicina del dolor y cuidado paliativo, Universidad Militar Nueva Granada, Bogotá, D. C., Colombia
Claudia Agamez, Instituto Nacional de Cancerología
Grupo de dolor y cuidado paliativo, Instituto Nacional de Cancerología, Bogotá, D. C., Colombia
Sandra Parra, Universidad Militar Nueva Granada
Medicina del dolor y cuidado paliativo, Universidad Militar Nueva Granada, Bogotá, D. C., Colombia
Grupo de dolor y cuidado paliativo, Instituto Nacional de Cancerología, Bogotá, D. C., Colombia
References
Soriano A, Davis MP. Malignant bowel obstruction: Individualized treatment for patients near the end of life. Cleve Clin J Med. 2011;78:197-206.
https://doi.org/10.3949/ccjm.78a.10052
Mercadante S, Ferrera P, Villari P, Marrazzo A. Aggressive Pharmacological Treatment for Reversing Malignant Bowel Obstruction. J Pain Symptom Manage. 2004;28:412-6.
https://doi.org/10.1016/j.jpainsymman.2004.01.007
DeBernardo R. Surgical Management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer. Curr Oncol Rep. 2009;11:287-92.
https://doi.org/10.1007/s11912-009-0040-4
Tuca A, Guell E, Martínez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Res. 2012;4:159-69.
https://doi.org/10.2147/CMAR.S29297
Anthony T, Barón T, Mercadante S, Green S, Chi D, Cunningham J, et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage. 2007; 34(Suppl 1):S49-S59.
https://doi.org/10.1016/j.jpainsymman.2007.04.011
Tuca A, Martínez E, Güell E, Gómez Baptiste X. Malignant bowel obstruction. Med Clin (Barc). 2010;135:375-81.
https://doi.org/10.1016/j.medcli.2010.03.002
Ripamonti C, Mercadante S. Pathophysiology and management of malignant bowel obstruction. En: Doyle D, Hanks G, Cherny N, Keneth C, editores. Oxford textbook of Palliative Medicine. 4.a ed. Oxford: Oxford University Press; 2010.
https://doi.org/10.1093/med/9780198570295.003.0069
Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: A qualitative systematic review. J Pain Symptom Manage. 2009;38:466-72.
Ripamonti C, Easson A, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105-15.
https://doi.org/10.1016/j.ejca.2008.02.028
Alesi E, Bobb B, Smith TJ. How we do it: Guiding patients facing decisions about "futile" chemotherapy. J Support Oncol. 2011; 9:184-7.
https://doi.org/10.1016/j.suponc.2011.04.001
Roeland E, Von Gunten Ch. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009;11:298-303.
https://doi.org/10.1007/s11912-009-0042-2
Krouse RS. Invasive treatment options for malignant bowel obstruction #119. J Palliat Med. 2009;12:1152-3.
https://doi.org/10.1089/jpm.2009.9922
Baron T. Interventional palliative strategies for malignant bowel obstruction. Curr Oncol Rep. 2009;11:293-7.
https://doi.org/10.1007/s11912-009-0041-3
Shaw C, Basset RL, Fox PS, Schmeler KM, Overman MJ, Wallace MJ, et al. Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol. 2013;20;497-505.
https://doi.org/10.1245/s10434-012-2643-5
Zhang Y, Shi J, Shi B, Song CY, Xie WF, Chen YX. Comparison of efficacy between uncovered and covered self expanding metallic stents in malignant large bowel obstruction: A systematic review and Meta-analysis. Colorectal Dis. 2012;14:367-74.
https://doi.org/10.1111/j.1463-1318.2012.03056.x
Jeurnink SM, Van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007;7:18.
https://doi.org/10.1186/1471-230X-7-18
Englert ZP, White MA, Fitzgerald TL, Vadlamundi A, Zervoudakis G, Zervos EE. Surgical management of malignant bowel obstruction: at what price palliation. Am Surg. 2012;78:647-52.
Courtney ED, Raja A, Leicester RJ. Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Dis Colon Rectum. 2005;48:845-50.
https://doi.org/10.1007/s10350-004-0833-3
Sherwood LA, Knowles G, Wilson RG, Potter MA. Retrospective review of laser therapy for palliation of colorectal tumours. Eur J Oncol Nurs. 2006;10:30-8.
https://doi.org/10.1016/j.ejon.2005.03.009
Von Gunten Ch, Muir JC. Medical management of bowel obstructions. J Palliat Med. 2009;12:1151-2.
https://doi.org/10.1089/jpm.2009.9923
Mercadante S, Porzio G. Octreotide for malignant bowel obstruction: Twenty years after. Crit Rev Oncol Hematol. 2012; 83:388-92.
https://doi.org/10.1016/j.critrevonc.2011.12.006
Laval G, Rosselot H, Toussain Martel S, Mayer F, Terrebonne E, François E, et al. SALTO: a randomized multicenter study assessing octreotide LAR in inoperable obstruction. Bull Cancer. 2012;99:E1-9.
https://doi.org/10.1684/bdc.2011.1535
Mariani B, Blumberg J, Landau A, Lebrun-Jenekova D, Botton E, Beatrix O, et al. Symptomatic treatment with Lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis. A randomized double-blind placebo controlled phase III study. J Clin Oncol. 2012;30;4337-43.
https://doi.org/10.1200/JCO.2011.40.5712
Kucukmetin A, Naik R, Galaal K, Bryant A, Dickinson HO. Palliative surgery versus medical management for bowel obstruction in ovarian cancer (Review) Cochrane Database Syst Rev. 2010:CD007792.
https://doi.org/10.1002/14651858.CD007792.pub2
Watari H, Hosaka M, Wakui Y, Nomura E, Hareyama H, Tanuma F, et al. A prospective study on the efficacy of octreotide in the management of malignant bowel obstruction in gynecologic cancer. Int J Gynecol Cancer. 2012;22:692-6.
https://doi.org/10.1097/IGC.0b013e318244ce93
Hinasaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, et al. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn J Clin Oncol. 2010;40:739-45.
https://doi.org/10.1093/jjco/hyq048
Feuer DJ, Broadley KE. Corticosteroides para la resolución de la obstrucción intestinal maligna en el cáncer avanzado ginecológico y gastrointestinal. Cochrane Database Syst Rev [internet]. 2008 [consultado 26 Ene 2013]. Disponible en: http://www.update-software.com
Levy MH, Adolph MD, Block S, Codada SN. Palliative Care. Symptoms: Malignant Bowel Obstruction. NCCN Clinical Practice Guidelines in Oncology Version 2 [internet]. 2012 [consultado 26 Ene 2013]. Disponible en: http://www.NCCN.org
Porzio G, Aielli F, Verna L, Galleti B, Shoja E, Razavi G, et al. Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer. 2011;19:431-33.
https://doi.org/10.1007/s00520-010-1009-4
Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R, et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction. Do the benefits outweigh the risks? Med Oncol. 2011;28:83-8.
https://doi.org/10.1007/s12032-010-9426-2
Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen-Celhar S, et al. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition. 2004;20:760-3.
https://doi.org/10.1016/j.nut.2004.05.010
Orrevall Y, Tishelman C, Permert J. Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr. 2005;24:961-70.
https://doi.org/10.1016/j.clnu.2005.06.008
Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, et al. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009;28:445-54.
https://doi.org/10.1016/j.clnu.2009.04.011
Withworth MK, Withfield A, Serena H, Shaffer J, Makin W, Jayson GC. Doctor, does this mean I ́m going to starve to death? JCO. 2004;22:199-201.
https://doi.org/10.1200/JCO.2004.02.056
Ng WC, Fung YLJ, Siu Man S, Ying Chang R. Short term and long-term outcomes of patients with malignant large bowel obstruction. Surg Pract. 2006;10:57-61.
https://doi.org/10.1111/j.1744-1633.2006.00293.x
Henry JC, Pouly S, Sullivan R, Sharif S, Klemanski D, Abdel-Misih S, et al. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery. 2012;152:747-57.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
